Patent Expiry
MIST: CARDAMYST: recorded patent 12257224 expiry
July 15, 2042 · ETRIPAMIL. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- July 15, 2042
- Company
- Milestone Pharmaceuticals Inc. (MIST)
- Drug
- ETRIPAMIL
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
CARDAMYST: recorded patent 12257224 expiry
Orange Book application NDA218571, product 001, listed patent 12257224 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- ETRIPAMIL